BioCentury | Jan 25, 2020
Emerging Company Profile

Aluda: targeting the fundamentals

...goal of discovering novel compounds that target fundamental processes associated with pathogenesis. Chen also co-founded Natrogen Therapeutics Intl. Inc....
BioCentury | Dec 23, 2013
Company News

Natrogen, Takeda deal

...Natura-alpha . Takeda also received an exclusive option to acquire Natrogen for an undisclosed amount. Natrogen...
...was legal advisor to Natrogen, and Ropes & Gray LLP was legal advisor to Takeda. Natrogen Therapeutics Intl. Inc....
BioCentury | Dec 20, 2013
Company News

Natrogen grants Takeda rights to Natura-alpha

...colitis (UC). Takeda also received an exclusive option to acquire Natrogen for an undisclosed amount. Natrogen...
...Takeda will be responsible for funding and conducting all additional clinical development. Leerink Swann advised Natrogen. BC...
Items per page:
1 - 3 of 3
BioCentury | Jan 25, 2020
Emerging Company Profile

Aluda: targeting the fundamentals

...goal of discovering novel compounds that target fundamental processes associated with pathogenesis. Chen also co-founded Natrogen Therapeutics Intl. Inc....
BioCentury | Dec 23, 2013
Company News

Natrogen, Takeda deal

...Natura-alpha . Takeda also received an exclusive option to acquire Natrogen for an undisclosed amount. Natrogen...
...was legal advisor to Natrogen, and Ropes & Gray LLP was legal advisor to Takeda. Natrogen Therapeutics Intl. Inc....
BioCentury | Dec 20, 2013
Company News

Natrogen grants Takeda rights to Natura-alpha

...colitis (UC). Takeda also received an exclusive option to acquire Natrogen for an undisclosed amount. Natrogen...
...Takeda will be responsible for funding and conducting all additional clinical development. Leerink Swann advised Natrogen. BC...
Items per page:
1 - 3 of 3